Navigation Links
HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
Date:2/23/2009

Net Operating Revenues Increased 6.7% with Strong Same Store Discharge Growth

Continued Progress on Debt Reduction

BIRMINGHAM, Ala., Feb. 23 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) today reported its results of operations for the fourth quarter ended December 31, 2008. The results showed consolidated net operating revenues of $463.8 million for the fourth quarter of 2008 compared to $434.5 million for the fourth quarter of 2007. This increase was driven by increased discharges quarter over quarter. Compared to the fourth quarter of 2007, consolidated net operating revenues increased by 6.7%. Diluted net income per share was $1.81 per share for the fourth quarter of 2008 compared to a loss of ($0.67) per share for the fourth quarter of 2007. On an adjusted basis, income (loss) from continuing operations was $0.24 per diluted share and ($0.01) per diluted share for the fourth quarters of 2008 and 2007, respectively (excludes amounts associated with government, class action, and related settlements, our loss on interest rate swap, and other non-recurring items; see attached supplemental information).

"The fourth quarter was another solid quarter for HealthSouth: same store discharges were up an impressive 9.7%; consolidated net operating revenues increased 6.7%; and adjusted earnings per share increased $0.25 per diluted share compared to the same period of last year," said Jay Grinney, President and Chief Executive Officer of HealthSouth. "We believe these results demonstrate the solid foundation and strength of HealthSouth's business model. We also believe our emphasis on providing high quality patient care and enhancing our balance sheet through continued debt repayment will position HealthSouth to achieve its previously targeted 15% to 20% EPS growth in 2009."

In addition, the Company continued to deleverage its balance sheet. During 2008, the Company used approximately $254 million of cash to reduce its total debt outstanding. Due to the addition of two capital leases for hospitals, the Company's net total debt reduction was approximately $228 million during the year. Total debt outstanding approximated $1.8 billion as of December 31, 2008. Total cash and cash equivalents as of December 31, 2008 approximated $32.2 million compared to $19.8 million as of December 31, 2007.

"Our ability to continue to generate cash from operations and non-operating sources allowed us to reduce our leverage ratio by a full turn in 2008," said John Workman, Executive Vice President and Chief Financial Officer. "We will continue to be disciplined in our use of cash in 2009 with a heavy focus towards debt reduction. In fact, we have reduced our debt by an additional $64 million, thereby reducing our leverage ratio by another 0.2 turn, since the end of 2008. "

2009 Guidance

Adjusted diluted earnings per share for 2009 is expected to be in the range of $0.85 to $0.90 per share, compared to $0.75 per diluted share in 2008. Adjusted diluted earnings per share excludes the fair value adjustments to the liability associated with the Company's securities litigation settlement that are required until the applicable common stock and warrants are issued, any gain or loss associated with the fair value adjustments to the Company's interest rate swap that is not classified as a hedge, professional fees (related primarily to the Company's derivative litigation), and other non-recurring items.

Adjusted Consolidated EBITDA for 2009 is expected to be in the range of $342.0 million to $352.0 million, compared to $341.8 million for 2008. The Company's Credit Agreement allows all unusual noncash items or nonrecurring charges to be added to arrive at Adjusted Consolidated EBITDA. See the Company's Current Report on Form 8-K furnished with this press release on February 23, 2009 for additional information related to the definition of Adjusted Consolidated EBITDA under the Company's Credit Agreement.

Other Information

The information in this press release is summarized and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2008 (the "2008 Form 10-K"), when filed, as well as the Company's Current Report on Form 8-K filed on February 23, 2009. In addition, the Company will post certain supplemental slides today on the investor section of its website at www.healthsouth.com for reference during its February 24, 2009 earnings call.

The Company expects to file its 2008 Form 10K this week. When filed, the report can be found on the investor section of the Company's website at www.healthsouth.com and the SEC's website at www.sec.gov.


                      HealthSouth Corporation and Subsidiaries
                   Condensed Consolidated Statements of Operations
                                     (Unaudited)

                                Three Months Ended        Year Ended
                                   December 31,          December 31,
                                 2008         2007      2008     2007
                                 (In Millions, Except Per Share Data)
    Net operating revenues     $463.8       $434.5  $1,842.4  $1,737.5
    Operating expenses:
     Salaries and benefits      233.7        217.4     934.7     863.6
     Other operating expenses    66.2         56.0     268.3     243.8
     General and
      administrative expenses    26.7         26.1     105.5     127.9
     Supplies                    27.8         25.4     108.9     100.3
     Depreciation and
      amortization               18.0         19.4      83.8      76.2
     Impairment of long-lived
      assets                        -            -       0.6      15.1
     Gain on UBS Settlement    (121.3)           -    (121.3)        -
     Occupancy costs             12.2         13.9      49.8      52.4
     Provision for doubtful
      accounts                    7.0          7.5      27.8      33.6
     Loss on disposal of
      assets                      1.4          3.6       2.0       5.9
     Government, class action,
      and related
      settlements expense       (39.3)        31.2     (67.2)     (2.8)
     Professional
      fees-accounting, tax,
      and legal                  31.5          7.3      44.4      51.6
     Total operating expenses   263.9        407.8   1,437.3   1,567.6
    Loss on early
     extinguishment of debt       0.1          8.3       5.9      28.2
    Interest expense and
     amortization of debt
     discounts and fees          28.4         51.9     159.7     229.8
    Other expense (income)        2.0         (0.9)     (0.1)    (15.5)
    Loss on interest rate
     swap                        39.6         23.6      55.7      30.4
    Equity in net income of
     nonconsolidated
     affiliates                  (2.8)        (2.9)    (10.6)    (10.3)
    Minority interests in
     earnings of consolidated
     affiliates                   8.1          8.2      29.8      31.4
     Income (loss) from
      continuing operations
      before income tax benefit 124.5        (61.5)    164.7    (124.1)
    Provision for income tax
     benefit                    (48.4)       (34.2)    (70.1)   (322.4)
     Income (loss) from
      continuing operations     172.9        (27.3)    234.8     198.3
    Income (loss) from
     discontinued operations,
     net of income tax benefit
      (expense)                   9.0        (18.6)     17.6     455.1
     Net income (loss)          181.9        (45.9)    252.4     653.4
    Convertible perpetual
     preferred stock
     dividends                   (6.5)        (6.5)    (26.0)    (26.0)
     Net income (loss)
      available to common
      shareholders             $175.4       $(52.4)   $226.4    $627.4
    Weighted average common
     shares outstanding:
     Basic                       87.4         78.6      83.0      78.7
     Diluted                    100.7         91.9      96.4      92.0
    Earnings (loss) per
     common share:
     Basic:
     Income (loss) from
      continuing operations
      available
      to common shareholders    $1.91       $(0.43)    $2.52     $2.19
     Income (loss) from
      discontinued operations,
      net of tax                 0.10        (0.24)     0.21      5.78
     Net income (loss) per
      share available to
      common shareholders       $2.01       $(0.67)    $2.73     $7.97

    Diluted:
     Income (loss) from
      continuing operations
      available
     to common shareholders     $1.72       $(0.43)    $2.44     $2.16
     Income (loss) from
      discontinued operations,
     net of tax                  0.09        (0.24)     0.18      4.94
     Net income (loss) per
      share available to
      common shareholders       $1.81       $(0.67)    $2.62     $7.10

                      HealthSouth Corporation and Subsidiaries
                        Condensed Consolidated Balance Sheets
                                     (Unaudited)

                                                           As of December 31,
                                                            2008       2007
                                                             (In Millions)
                           Assets
    Current assets:
     Cash and cash equivalents                             $32.2      $19.8
     Restricted cash                                       154.0       63.6
     Restricted marketable securities                       20.3       28.9
     Accounts receivable, net of allowance for doubtful
      accounts of $31.1
     in 2008; $37.6 in 2007                                235.9      217.7
     Other current assets                                   55.1       58.4
     Insurance recoveries receivable                       182.8      230.0
     Current assets held for sale                            2.4       19.0
     Total current assets                                  682.7      637.4
    Property and equipment, net                            674.3      729.6
    Goodwill                                               414.7      406.1
    Intangible assets, net                                  42.8       26.1
    Investments in and advances to nonconsolidated
     affiliates                                             36.7       42.7
    Assets held for sale                                    24.5       78.0
    Income tax refund receivable                            55.9       52.5
    Other long-term assets                                  66.6       78.2
     Total assets                                       $1,998.2   $2,050.6
           Liabilities and Shareholders' Deficit
    Current liabilities
     Current portion of long-term debt                     $24.8      $68.3
     Accounts payable                                       45.7       48.7
     Accrued expenses and other current liabilities        371.8      364.2
     Government, class action, and related settlements     268.5      400.7
     Current liabilities held for sale                      35.4       88.6
       Total current liabilities                           746.2      970.5
    Long-term debt, net of current portion               1,789.6    1,974.4
    Liabilities held for sale                                3.8        4.2
    Other long-term liabilities                            158.4      171.4
                                                         2,698.0    3,120.5
    Commitments and contingencies
    Minority interest in equity of consolidated
     affiliates                                             82.2       97.2
    Convertible perpetual preferred stock                  387.4      387.4
    Shareholders' deficit:
       Total shareholders' deficit                      (1,169.4)  (1,554.5)
     Total liabilities and shareholders' deficit        $1,998.2   $2,050.6

                 HealthSouth Corporation and Subsidiaries
              Condensed Consolidated Statements of Cash Flows

                                                          Year Ended
                                                         December 31,
                                                       2008           2007
                                                         (In Millions)
    Net cash provided by operating activities        $227.2         $230.6
    Net cash (used in) provided by investing
     activities                                       (40.0)       1,184.5
    Net cash used in financing activities            (176.0)      (1,436.6)
    Effect of exchange rate changes on cash and cash
     equivalents                                        0.8            0.1
    Increase (decrease) in cash and cash equivalents   12.0          (21.4)
    Cash and cash equivalents at beginning of year     19.8           27.2
    Cash and cash equivalents of divisions and
     facilities held for sale at beginning of year      0.4           14.4
    Less: Cash and cash equivalents of divisions and
     facilities held for sale at end of year              -           (0.4)
    Cash and cash equivalents at end of year          $32.2          $19.8

Operating activities. Net cash provided by operating activities in 2008 and 2007 included federal income tax refunds of approximately $46 million and $440 million, respectively. If the Company excludes these cash refunds in each year, its net cash provided by (used in) operating activities becomes $181.2 million and ($209.4) million, respectively, or a year-over-year improvement of $390.6 million. Net cash provided by operating activities increased year over year due to an increase in net operating revenues, a decrease in cash interest expense, and a decrease in cash settlement payments related primarily to the Company's Medicare Program Settlement negotiated in 2004 and its SEC Settlement negotiated in 2005. The year ended December 31, 2008 included cash settlement payments of $7.4 million related primarily to the Company's settlement with the United States Department of Health and Human Services Office of Inspector General negotiated in 2007.

Investing activities. The decrease in net cash provided by investing activities was due to the cash proceeds received from the divestitures of the Company's surgery centers, outpatient, and diagnostic divisions during 2007. Net cash used in investing activities for 2008 included $39.2 million in expenditures associated with the Company's development activities, including $6.4 million of capital expenditures associated with land purchases for de novo projects.

Financing activities. The decrease in net cash used in financing activities was due to the use of the cash proceeds from the divestitures of the Company's surgery centers, outpatient, and diagnostic divisions to reduce debt outstanding under its Credit Agreement during 2007. During 2008, the Company made approximately $254.2 million of net debt payments. During 2007, the Company made approximately $1.3 billion of net debt payments. The net debt payments made during 2008 primarily resulted from the sale of the Company's corporate campus in March 2008, the net proceeds from its June 2008 equity offering, and the Company's federal income tax recovery in October 2008.


                     HealthSouth Corporation and Subsidiaries
                         Supplemental Non-GAAP Disclosures
           Reconciliation of Net Income (Loss) to Adjusted Income (Loss)
                           from Continuing Operations
                    and Adjusted Consolidated EBITDA (1) (5)

                                         Three Months Ended December 31,
                                     2008        Per       2007      Per
                                               Share(2)           Share(2)
                                     (In Millions, Except per Share Data)
    Net income (loss)              $181.9        $2.08    $(45.9)    $(0.58)
    (Income) loss from discontinued
     operations                      (9.0)       (0.10)     18.6       0.24
    Income (loss) from continuing
     operations                     172.9         1.98     (27.3)     (0.35)

    Gain on UBS Settlement         (121.3)       (1.39)        -          -
    Government, class action, and
     related settlements            (39.3)       (0.45)     31.2       0.40
    Professional fees - accounting,
     tax, and legal                  31.5         0.36       7.3       0.09
    Loss on interest rate swap       39.6         0.45      23.6       0.30
    Interest associated with UBS
     Settlement (4)                  (9.4)       (0.11)        -          -
    Provision for income tax
     Benefit                        (48.4)       (0.55)    (34.2)     (0.44)
    Estimated state tax expense      (1.3)       (0.01)     (1.3)     (0.02)
    Adjusted income (loss) from
     Continuing operations (1) (5)   24.3         0.28      (0.7)     (0.01)
    Adjustment to GAAP EPS for
     dilution (2)                                (0.04)                   -
    Adjusted income (loss) from
     continuing operations
     per diluted share (2) (5)                   $0.24               $(0.01)

    Estimated state tax expense       1.3                    1.3
    Interest expense and
     amortization of debt discounts
     and fees, excluding interest
     associated with UBS Settlement  37.8                   51.9
    Depreciation and amortization    18.0                   19.4
                                     81.4                   71.9
    Other adjustments per the
     Company's Credit Agreement:
     Impairment charges related to
      investments                     1.8                      -
     Net noncash loss on disposal of
      assets                          1.4                    3.6
     Loss on early extinguishment of
      debt                            0.1                    8.3
     Compensation expense under FASB
      Statement No. 123(R)            3.2                    2.5
     Other                           (0.1)                   0.1
    Adjusted Consolidated EBITDA
      (1) (5) (6)                   $87.8                  $86.4

    Weighted average common shares
     outstanding:
    Basic                                         87.4                 78.6
    Diluted                                      100.7                 91.9


                       HealthSouth Corporation and Subsidiaries
                           Supplemental Non-GAAP Disclosures
                  Reconciliation of Net Income to Adjusted Income (Loss)
                               from Continuing Operations
                        and Adjusted Consolidated EBITDA (1) (5)

                                             Year Ended December 31,
                                       2008      Per      2007        Per
                                               Share(2)            Share(2)
                                       (In Millions, Except per Share Data)

    Net income                        $252.4    $3.04    $653.4     $8.30
    Income from discontinued
     operations                        (17.6)   (0.21)   (455.1)    (5.78)
    Income from continuing operations  234.8     2.83     198.3      2.52

    Gain on UBS Settlement            (121.3)   (1.46)        -         -
    Government, class action, and
     related settlements               (67.2)   (0.81)     (2.8)    (0.04)
    Professional fees - accounting,
     tax, and legal                     44.4     0.53      51.6      0.66
    Loss on interest rate swap          55.7     0.67      30.4      0.39
    Accelerated depreciation of
     corporate campus (3)               10.0     0.12         -         -
    Gain on sale of investment in
     Source Medical                        -        -      (8.6)    (0.11)
    Interest associated with UBS
     Settlement (4)                     (9.4)   (0.11)        -         -
    Provision for income tax benefit   (70.1)   (0.84)   (322.4)    (4.10)
    Estimated state tax expense         (5.0)   (0.06)     (5.0)    (0.06)
    Adjusted income (loss) from
     Continuing operations (1) (5)      71.9     0.87     (58.5)    (0.74)
    Adjustment to GAAP EPS for
     dilution (2)                               (0.12)               0.10
    Adjusted income (loss) from
     continuing operations
     per diluted share (2) (5)                  $0.75              $(0.64)

    Estimated state tax expense          5.0                5.0
    Interest expense and amortization
     of debt discounts and fees,
     excluding interest associated
     with UBS Settlement               169.1              229.8
    Depreciation and amortization,
     excluding accelerated
     depreciation of corporate campus   73.8               76.2
                                       319.8              252.5
    Other adjustments per the
     Company's
     Credit Agreement:
     Impairment charges, including
      investments                        2.4               15.1
     Net noncash loss on disposal of
      assets                             2.0                5.9
     Loss on early extinguishment of
      debt                               5.9               28.2
     Gain on sale of investment in
      Source Medical                       -                8.6
     Compensation expense under FASB
      Statement No. 123(R)              11.7               10.6
     Other                                 -                0.4
    Adjusted Consolidated EBITDA
     (1)(5)(6)                        $341.8             $321.3

    Weighted average common shares
     outstanding:
    Basic                                        83.0                78.7
    Diluted                                      96.4                92.0


HealthSouth Corporation and Subsidiaries

Supplemental Non-GAAP Disclosures

Notes to Reconciliations

(1) Adjusted income (loss) from continuing operations and Adjusted Consolidated EBITDA are non-GAAP financial measures. Management and some members of the investment community utilize adjusted income (loss) from continuing operations as a financial measure and Adjusted Consolidated EBITDA as a liquidity measure on an ongoing basis. These measures are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance or liquidity. In evaluating these adjusted measures, the reader should be aware that in the future HealthSouth may incur expenses similar to the adjustments set forth above.

(2) Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts except adjusted income (loss) from continuing operations per diluted share, which is based on diluted shares outstanding. The diluted share counts contain approximately 13.1 million shares related to the potential dilution of the Company's convertible perpetual preferred stock. Per share amounts do not include 5.0 million shares of common stock or warrants to purchase approximately 8.2 million shares of common stock not yet issued under the securities litigation settlement. The increase in the Company's basic and diluted weighted average common shares outstanding for the three months and year ended December 31, 2008 compared to the same periods of 2007 was primarily the result of its equity offering of 8.8 million shares that was completed on June 27, 2008. The calculation of adjusted loss from continuing operations per diluted share ignores the antidilutive impact in 2007.

(3) In the first quarter of 2008, and in accordance with Financial Accounting Standards Board Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company accelerated the depreciation of its corporate campus so that the net book value of the campus equaled the estimated net proceeds the Company expected to receive on the sale transaction's closing date. The year-over-year impact of this acceleration of depreciation approximated $10 million. No similar charges are expected in 2009.

(4) Interest expense and amortization of debt discounts and fees in the Company's consolidated statements of operations for the three months and year ended December 31, 2008 included the reversal of approximately $9.4 million of accrued interest related to the loan guarantee for which the Company received a release as part of the UBS Settlement.

(5) Adjusted income (loss) from continuing operations per diluted share and Adjusted Consolidated EBITDA are two components of the Company's guidance.

(6) The Company's Credit Agreement allows all unusual non-cash items or non-recurring charges to be added to arrive at Adjusted Consolidated EBITDA. In addition, the Company is allowed to add investment and other income, including interest income, as well as non-recurring cash gains, to the calculation of Adjusted Consolidated EBITDA under its Credit Agreement. This includes interest income associated with the Company's federal income tax recoveries and the estimated cash proceeds from legal settlements, such as the UBS Settlement. These amounts have not been included in the above calculation as it would not be indicative of the Company's Adjusted Consolidated EBITDA for future periods.

The Company will host an investor conference call at 9:30 a.m. Eastern Time on Tuesday, February 24, 2009 to discuss its results for the fourth quarter and year ended December 31, 2008. For reference during the call, the Company will post certain supplemental slides on the investor section of its website at www.healthsouth.com.

The conference call may be accessed by dialing 8664065369 and giving the pass code 76626362. International callers should dial 9735822847 and give the same pass code. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available in the investor section of its website, www.healthsouth.com, by clicking on an available link.

A replay of the conference call will be available, beginning approximately two hours after the completion of the conference call, from February 24 until March 10, 2009. To access the replay, please dial 8006421687. International callers should dial 7066459291. The webcast will also be archived for replay purposes after the live broadcast in the investor section of www.healthsouth.com.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitative services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitation services and can be found on the Web at www.healthsouth.com.

Statements contained in this press release which are not historical facts are forward-looking statements. In addition, HealthSouth, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and HealthSouth undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. HealthSouth's actual results may differ materially from the results anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results to differ materially from those estimated by HealthSouth include, but are not limited to, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought against the Company; significant changes in HealthSouth's management team; HealthSouth's ability to continue to operate in the ordinary course and manage its relationships with its creditors, including its lenders, bondholders, vendors and suppliers, employees, and customers; changes, delays in, or suspension of reimbursement for HealthSouth's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and HealthSouth's response thereto; HealthSouth's ability to obtain and retain favorable arrangements with third-party payors; HealthSouth's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages; general conditions in the economy and capital markets; and other factors which may be identified from time to time in the Company's SEC filings and other public announcements, including HealthSouth's Form 10K for the year ended December 31, 2008, which is expected to be filed later this week.

    Media Contact
    Andy Brimmer, 205-410-2777
    Investor Relations Contact
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com


'/>"/>
SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Corporation Appoints New Member to Board of Directors
3. HealthSouth Announces Date of Third Quarter Earnings Conference Call
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
6. HealthSouth Issues Statement on Medicare Bill and 75% Rule
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
10. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
11. HealthSouth Announces Date of 2008 First Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TherapySites, the leading website and ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to extend ... exclusive benefits and promotional offers. , "TCA is extremely excited about this new ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
Breaking Medicine Technology: